Author Interviews, Diabetes, Nature, University of Michigan / 23.01.2015
Potential Drug Targets To Prevent Hypoglycemia in Diabetics Identified
MedicalResearch.com Interview with:
Martin G. Myers, Jr., M.D., M.P.H.
Director, Michigan Diabetes Research & Training Center
Associate Professor of Internal Medicine - MEND Division
Professor of Molecular & Integrative Physiology
Marilyn H. Vincent Professor of Diabetes Research and
Department of Pharmacology, University of Cambridge, Cambridge
Medical Research: What is the background for this study? What are the main findings?
Dr. Myers: Diabetic people who take insulin to treat their diabetes are at risk of low blood sugar, which can cause serious consequences (including death). This risk increases as blood sugar control improves, and so this risk limits the ability to control blood sugar. The body has a system (the counter-regulatory response) that acts to prevent blood sugar from going too low, but this is often impaired in diabetic patients.
We identified a brain circuit that senses and responds to falling blood sugar, and which acts to increase blood sugar. Furthermore, we showed that the hormone leptin modulates the sensitivity of this circuit, and identified the neurotransmitter (CCK) that acts in this circuit to increase blood sugar. Thus, we have identified several potential drug targets that could be used to prevent or treat low blood sugar in insulin-treated diabetics. If we are able to pharmacologically modulate the activity of this brain circuit, it could improve the treatment of these patients. (more…)